Phase II study of protracted daily temozolomide for low-grade gliomas in adults

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
S KesariPatrick Y Wen

Abstract

Resistance to temozolomide chemotherapy is partly mediated by O(6)-methylguanine-DNA methlytransferase (MGMT). Protracted treatment with temozolomide potentially overcomes MGMT resistance and improves outcome. We conducted a phase II study of protracted daily temozolomide in adults with low-grade gliomas. Patients with newly diagnosed oligodendroglioma or oligoastrocytoma with a MIB-1 index of >5% or recurrent low-grade gliomas received temozolomide (75 mg/m(2)/day in 11-week cycles of 7 weeks on/4 weeks off). Treatment continued for a total of six cycles or until tumor progression or unacceptable toxicity. Primary end point was best overall response rate; secondary end points were progression-free survival, overall survival, and toxicity. We correlated response with MGMT promoter methylation and chromosome 1p/19q deletion status. Forty-four patients were treated (14 female, 30 male) with a median follow-up of 39.4 months. Median age was 43 years (range, 20-68 years) and median Karnofsky performance status was 90 (range, 70-100). The regimen was well tolerated. No patients had a complete response (0%), 9 had partial response (20%), 33 had stable disease (75%), and 2 had progressive disease (5%). A total of 21 patients eventuall...Continue Reading

References

Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Jan 1, 1996·Neurology·W P MasonL M DeAngelis
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C LeightonG Cairncross
Nov 5, 1998·Neurosurgery·R SoffiettiD Schiffer
Jan 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jan C BucknerRobert Jenkins
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer A QuinnHenry S Friedman
Jun 28, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J van den BentUNKNOWN European Organization for Research and Treatment of Cancer Brain Tumor Group
Nov 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M BradaC Westbury
Nov 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A PaceC M Carapella
Jun 2, 2004·Nature Reviews. Cancer·Robert S Kerbel, Barton A Kamen
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Hoang-XuanJ Y Delattre
Sep 15, 2004·Neurology·V H J M TriebelsM J van den Bent
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Sep 20, 2005·Lancet·M J van den BentUNKNOWN EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council
Feb 16, 2006·Neurology·A TosoniA A Brandes
Nov 4, 2006·Journal of Neuro-oncology·Nader PouratianDavid Schiff
Dec 29, 2006·Annals of Neurology·Sibille EverhardJoëlle Thillet
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel P CahillDavid N Louis
Apr 25, 2007·Neuro-oncology·Santosh KesariPatrick Y Wen
May 23, 2007·Neurology·Patrick Y Wen, Lisa M DeAngelis
Sep 26, 2007·Neurology·David SchiffCaterina Giannini
Oct 2, 2007·Current Opinion in Oncology·Ahmed IdbaihKhê Hoang-Xuan
Dec 20, 2007·Journal of Neuropathology and Experimental Neurology·Martin J van den Bent, Johan M Kros

❮ Previous
Next ❯

Citations

Aug 21, 2010·Targeted Oncology·Markus J RiemenschneiderGuido Reifenberger
Apr 29, 2010·Current Neurology and Neuroscience Reports·Nader Pouratian, David Schiff
Jul 17, 2012·Current Treatment Options in Neurology·Shaheryar Hafeez, Robert Cavaliere
May 22, 2013·Clinical Oncology : a Journal of the Royal College of Radiologists·A SahgalL Paszat
Dec 10, 2009·Nature Reviews. Neurology·Michael WellerMonika E Hegi
Nov 4, 2010·Nature Reviews. Neurology·T David Bourne, David Schiff
Dec 7, 2013·Neuro-oncology·Jiaxin ZhaoHong Zhao
Aug 24, 2012·Current Opinion in Oncology·Aurélien ViaccozFrançois Ducray
Aug 20, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R SoffiettiW Wick
Mar 7, 2012·Journal of Translational Medicine·Annette Bentsen HåvikGuro Elisabeth Lind
Aug 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward G ShawMinesh P Mehta
Oct 14, 2011·Future Oncology·Mersiha HadziahmetovicArnab Chakravarti
Aug 23, 2011·Journal of Neurosurgery·David Schiff
Mar 29, 2014·Neuro-oncology·Seunggu J HanNicholas A Butowski
Jun 11, 2014·Nature Reviews. Neurology·Wolfgang WickGuido Reifenberger
Sep 1, 2014·Seminars in Oncology·Abdulrazag Ajlan, Lawrence Recht
Jan 3, 2013·British Journal of Neurosurgery·R MaR Stacey
Jan 17, 2012·Biochimica Et Biophysica Acta·John R SilberMarc C Chamberlain
Apr 5, 2011·Translational Oncology·Céline BruyèreFlorence Lefranc
Sep 13, 2011·Revue neurologique·F Ducray
Sep 8, 2010·Neurologic Clinics·Vikram C PrabhuJohn M Lee
Sep 6, 2014·Journal of Neuropathology and Experimental Neurology·Takashi OhtaHiroko Ohgaki
Mar 18, 2011·Genes, Chromosomes & Cancer·Hanne-Sofie S DahlbackSverre Heim
Dec 7, 2010·Brain Pathology·Andreas von DeimlingChristian Hartmann
Apr 19, 2011·European Journal of Clinical Investigation·Ann I McCormackAshley B Grossman
Oct 20, 2015·CNS Oncology·Caroline Chung, Normand Laperriere
Nov 16, 2010·The American Journal of Pathology·Young-Ho KimHiroko Ohgaki
Mar 7, 2015·Neurologia Medico-chirurgica·Motoo Nagane
Jun 9, 2015·Seminars in Radiation Oncology·Adriana Olar, Erik P Sulman
Feb 15, 2015·International Journal of Radiation Oncology, Biology, Physics·Barbara J FisherMinesh Mehta
Feb 24, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Roel H Wilting, Jan-Hermen Dannenberg
Jul 23, 2013·The Journal of Molecular Diagnostics : JMD·Milena CankovicEudocia Q Lee
Jan 20, 2015·Neurosurgical Focus·Masayuki NittaYoshikazu Okada
Jan 2, 2015·Neurosurgical Focus·Elizabeth B ClausMargaret Wrensch
Jul 2, 2016·Journal of Neurosciences in Rural Practice·Lorenzo Curtò
Jun 27, 2015·Neuro-oncology·Gelareh ZadehDavid Schiff
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James R PerryJean-François Pouliot
Aug 16, 2017·Cancer Chemotherapy and Pharmacology·Michael A BadruddojaMichael Malek Ahmadi
Jul 22, 2014·Journal of Korean Medical Science·So Hyun BaeChae-Yong Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.